MTI Ltd. Financial Summary for the Fiscal Year Ended September 2026

Performance Overview

MTI Ltd. continues to pursue growth centered on its Healthcare and School DX businesses. Although revenue increased, SG&A expanded due to higher development expenses related to pharmacy DX and increased costs for "Lunarna Mira Support", resulting in a decline in operating income year on year. By segment, growth drivers remain intact with expansion in School DX and an increase in store installations for Healthcare. Expansion of cloud-based pharmacy records and the launch of next-generation cloud receipt systems are expected to contribute to medium- to long-term revenue stabilization.

Outlook and Impact on Investors

The company emphasizes revenue expansion in School DX and Healthcare as drivers of medium- to long-term growth. It aims to secure new revenue sources through cumulative increases in BLEND implementation schools, expanded collaboration with local governments, and strengthened municipal partnerships for Lunarna. For the fiscal year ending September 2027, full-year guidance forecasts revenue of 33,000 million yen, operating income of 2,800 million yen, and net income of 700 million yen, though short-term cost increases may have an impact.